Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Medical Officer | April 01, 2026 | April 02, 2026 |
| OS Therapies IncOSTX · Entity 6950 | Director | July 01, 2026 | July 23, 2026 |
| Q/C TECHNOLOGIES, INC.MYMD · Entity 7735 | Director | June 07, 2023 | June 09, 2023 |
| Telomir Pharmaceuticals, Inc.TELO · Entity 6962 | Director | February 08, 2024 | February 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date April 01, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,001 |
Ending reported balance
After 2026-04-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-04-01 · Exercise / conversion · Acquired 1,714 · Balance 68,094 Row 2 · 2026-04-01 · Exercise / conversion · Acquired 1,667 · Balance 69,761 Row 3 · 2026-04-01 · Exercise / conversion · Acquired 2,660 · Balance 72,421 Row 4 · 2026-04-01 · Exercise / conversion · Acquired 5,359 · Balance 77,780 Row 5 · 2026-04-01 · Tax withholding · Disposed 5,779 · Balance 72,001 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,429 |
Reported balance
After 2026-04-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-01 · Exercise / conversion · Disposed 1,714 · Balance 3,429 F2: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,335 |
Reported balance
After 2026-04-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-01 · Exercise / conversion · Disposed 1,667 · Balance 3,335 F4: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 15,955 |
Reported balance
After 2026-04-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-04-01 · Exercise / conversion · Disposed 2,660 · Balance 15,955 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 10,883 |
Reported balance
After 2026-04-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-04-01 · Exercise / conversion · Disposed 5,359 · Balance 10,883 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
OS Therapies Inc
Report date July 01, 2026 · Filed July 23, 2026
This filing explicitly reported no securities owned.
Q/C TECHNOLOGIES, INC.
Report date June 07, 2023 · Filed June 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.66 · Expires 2028-06-07 | Direct | 475,000 |
Reported balance
After 2023-06-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-07 · Grant · Acquired 475,000 · Balance 475,000 F1: The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date.
Telomir Pharmaceuticals, Inc.
Report date February 08, 2024 · Filed February 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 487,805 |
Reported balance
Holding disclosure · report date 2024-02-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 487,805 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2025 Filed Apr 2, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000114 · wk-form4_1743629620.xml · derivative · entry 4 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,285 Underlying: Common Stock · 1,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vest in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,295 | $42.47 | $54,998.65 |
DisclosureSEC source: 0001576280-25-000114 · wk-form4_1743629620.xml · nonDerivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,600 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000114 · wk-form4_1743629620.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000114 · wk-form4_1743629620.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,401 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000090 · wk-form4_1742333091.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,010 Underlying: Common Stock · 1,401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 500 | $42.89 | $21,445.00 |
DisclosureSEC source: 0001576280-25-000090 · wk-form4_1742333091.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,514 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 21:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000090 · wk-form4_1742333091.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:32 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 16,242 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000070 · wk-form4_1741897930.xml · derivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,242 Underlying: Common Stock · 16,242 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 20:32 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 24,363 | $0.00 Strike: $43.10 | $0.00 |
DisclosureSEC source: 0001576280-25-000070 · wk-form4_1741897930.xml · derivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,363 Underlying: Common Stock · 24,363 shares Expires 2035-03-12 F1 · derivative.exercise_date: This represents a stock option award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vests on April 1, 2026, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 5,686 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000054 · wk-form4_1741129812.xml · derivative · entry 4 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,376 Underlying: Common Stock · 5,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 2,029 | $42.55 | $86,333.95 |
DisclosureSEC source: 0001576280-25-000054 · wk-form4_1741129812.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,613 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000054 · wk-form4_1741129812.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000012 · wk-form4_1735945082.xml · derivative · entry 5 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,671 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000012 · wk-form4_1735945082.xml · derivative · entry 4 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,999 Underlying: Common Stock · 1,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,387 | $30.55 | $42,372.85 |
DisclosureSEC source: 0001576280-25-000012 · wk-form4_1735945082.xml · nonDerivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,956 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000012 · wk-form4_1735945082.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000012 · wk-form4_1735945082.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,402 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000305 · wk-form4_1734390865.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,411 Underlying: Common Stock · 1,402 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 711 | $34.76 | $24,714.36 |
DisclosureSEC source: 0001576280-24-000305 · wk-form4_1734390865.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,962 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 15, 2024 Filed Dec 16, 2024 23:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000305 · wk-form4_1734390865.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:10 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 31,751 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000269 · wk-form4_1731453020.xml · derivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,751 Underlying: Common Stock · 31,751 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:10 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 47,627 | $0.00 Strike: $28.61 | $0.00 |
DisclosureSEC source: 0001576280-24-000269 · wk-form4_1731453020.xml · derivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,627 Underlying: Common Stock · 47,627 shares Expires 2034-11-08 F1 · derivative.exercise_date: This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2025, and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,569 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000236 · wk-form4_1727902291.xml · derivative · entry 5 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,338 Underlying: Common Stock · 6,569 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F5 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,715 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000236 · wk-form4_1727902291.xml · derivative · entry 4 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,713 Underlying: Common Stock · 1,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,200 | $22.12 | $92,904.00 |
DisclosureSEC source: 0001576280-24-000236 · wk-form4_1727902291.xml · nonDerivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,271 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000236 · wk-form4_1727902291.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:51 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000236 · wk-form4_1727902291.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,402 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000214 · wk-form4_1726522106.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,813 Underlying: Common Stock · 1,402 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 711 | $26.79 | $19,047.69 |
DisclosureSEC source: 0001576280-24-000214 · wk-form4_1726522106.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,187 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 15, 2024 Filed Sep 16, 2024 21:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000214 · wk-form4_1726522106.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000166 · wk-form4_1719953660.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,428 Underlying: Common Stock · 1,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 612 | $28.26 | $17,295.12 |
DisclosureSEC source: 0001576280-24-000166 · wk-form4_1719953660.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,496 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000166 · wk-form4_1719953660.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:38 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 5,523 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000146 · wk-form4_1718663924.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,215 Underlying: Common Stock · 5,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:38 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,971 | $30.21 | $59,543.91 |
DisclosureSEC source: 0001576280-24-000146 · wk-form4_1718663924.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,394 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 15, 2024 Filed Jun 17, 2024 22:38 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000146 · wk-form4_1718663924.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 3,717 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000115 · wk-form4_1715897626.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,718 Underlying: Common Stock · 3,717 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on May 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of May 15, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 1,327 | $25.75 | $34,170.25 |
DisclosureSEC source: 0001576280-24-000115 · wk-form4_1715897626.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,842 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| May 15, 2024 Filed May 16, 2024 22:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 3,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000115 · wk-form4_1715897626.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000080 · wk-form4_1712095512.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,142 Underlying: Common Stock · 1,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 621 | $20.25 | $12,575.25 |
DisclosureSEC source: 0001576280-24-000080 · wk-form4_1712095512.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,452 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000080 · wk-form4_1712095512.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 1,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000006 · wk-form4_1704329059.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,856 Underlying: COMMON STOCK · 1,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 703 | $27.05 | $19,016.15 |
DisclosureSEC source: 0001576280-24-000006 · wk-form4_1704329059.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,359 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000006 · wk-form4_1704329059.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:20 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 19,907 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000211 · wk-form4_1702678828.xml · derivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,907 Underlying: COMMON STOCK · 19,907 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:20 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 29,861 | $0.00 Strike: $28.37 | $0.00 |
DisclosureSEC source: 0001576280-23-000211 · wk-form4_1702678828.xml · derivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,861 Underlying: COMMON STOCK · 29,861 shares Expires 2033-12-13 F1 · derivative.exercise_date: This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 6,856 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000167 · wk-form4_1696281486.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,570 Underlying: COMMON STOCK · 6,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 2,371 | $29.64 | $70,276.44 |
DisclosureSEC source: 0001576280-23-000167 · wk-form4_1696281486.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,348 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 6,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000167 · wk-form4_1696281486.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.